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Lateral femoral cutaneous nerve block with
different volumes of Ropivacaine: a
randomized trial in healthy volunteers
Frederik Vilhelmsen1,2* , Mariam Nersesjan1,2, Jakob Hessel Andersen2, Jakob Klim Danker2, Leif Broeng3,
Daniel Hägi-Pedersen1, Ole Mathiesen2 and Kasper Højgaard Thybo1
Abstract
Background: Nerve block of the lateral femoral cutaneous nerve (LFCN) is a predominantly sensory block. It
reduces pain following total hip arthroplasty (THA), but the non-responder rate is high. We hypothesized, that an
increased volume of ropivacaine, would result in greater coverage of incisions used for THA.
Methods: We conducted a randomized, blinded trial in 20 healthy volunteers. Participants were randomized to
receive bilateral LFCN-blocks with 8 mL ropivacaine 0.75% on the left side and 16 mL ropivacaine 0.75% on the
right side, or vice versa. Allocation was blinded to both participants and outcome assessors. Before nerve block
performance, incision lines for posterior and lateral THA approaches were depicted with invisible ultraviolet-paint,
thereby securing sufficient blinding during outcome assessment. The blocked area was mapped using temperature
and mechanical discrimination tests. Quadriceps muscle strength was monitored. Primary outcome was coverage of
the posterior incision line assessed by temperature discrimination test.
Results: We found no difference in coverage of the posterior or lateral incision lines when comparing LFCN-blocks
with 8 mL versus 16 mL of ropivacaine. The blocked area was significantly larger in the 16 mL group, assessed by
both temperature discrimination test (p = 0.012) and mechanical discrimination test (p = 0.034). We observed no
difference between groups regarding quadriceps muscle strength (p = 1.0).
Conclusions: A LFCN-block with increased volume of ropivacaine from 8mL to 16 mL did not result in a greater
coverage of posterior or lateral incision lines used for THA, but in a larger blocked sensory area.
Trial registration: Clinicaltrials.gov: NCT03138668. Registered 3rd of May 2017.
Keywords: Regional anesthetics, Lateral femoral cutaneous nerve block, Total hip arthroplasty, Ropivacaine,
Anatomy, Clinical trial
Background
Total hip arthroplasty (THA) is often associated with
moderate to severe postoperative pain [1] and peripheral
nerve blocks have been used as part of a multimodal an-
algesic strategy [2–5]. The use of peripheral nerve blocks
may be hindered by an accompanying motor blockade,
which may lead to increased risk of falling [6].
The lateral femoral cutaneous nerve (LFCN) block is a
predominantly sensory block and has been suggested to
mitigate pain after hip surgery [7–9]. A clinical trial
from 2016 showed that LFCN-blocks with 8mL ropiva-
caine 0.75% reduced moderate to severe movement
related pain after THA surgery using the posterior
approach, but the non-responder rate was high (42%)
[8]. Recently, several other studies have investigated the
anatomical sensory distribution of a LFCN-block and
consistently revealed a limited coverage of THA
incisions using 5 to 10mL of local anesthetics [10–12].
The LFCN most commonly originates from L2 and L3
spinal nerves and travels across the iliac muscle towards
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the anterior superior iliac spine (ASIS) as one single
nerve, before passing beneath the inguinal ligament (IL).
In most cases it divides immediately into two branches
distal to the IL and continues superficially to supply the
lateral aspect of the thigh. However various branching
patterns and points of exit from the pelvis have been re-
ported. Variations include, but are not limited to, bifur-
cation or even trifurcation within the pelvis, exits point
through the IL, lateral to the ASIS, or through the ASIS.
[13–15]. The LFCN has recently been described as being
placed in its own fascial canal in the thigh, named the
LFCN-canal [16] or fat-filled flat tunnel [10], created by
a splitting of the fascia latae forming a lumen in which
the nerve lies.
We hypothesized that injection of a larger volume of
local anesthetic could migrate both proximally and
distally within the above-described canal, spreading to
additional lesser, local cutaneous branches arising from
LFCN, thereby giving rise to a greater blocked distribu-
tion area. In this trial, we investigate if LFCN-blocks
with 16mL ropivacaine results in a greater coverage of
the incision line for the posterior THA approach com-
pared with LFCN-blocks with 8 mL ropivacaine, assessed
by temperature discrimination test (primary outcome).
Methods
We conducted a randomized, blinded trial in healthy
volunteers at the Department of Anesthesiology, Zealand
University Hospital Koege, Denmark from the 19th of
May 2017 to the 9th of June 2017.
Participants
Inclusion criteria were: ≥ 18 years of age, American
Society of Anesthesiologists physical status classification
(ASA) score of I or II, Body Mass Index between 18 and
30. Exclusion criteria were inability to understand or
speak Danish, inability to cooperate, allergies to ropiva-
caine, alcohol or drug abuse (investigators judgement),
consumption of prescription-required analgesic drugs
within four weeks before the trial date or over-the-coun-
ter analgesic drugs within 48 h of trial date, neuromus-
cular defects, former surgery in lower extremity, large
tattoos or trauma on the thigh or hip, and diabetes melli-
tus. Women had to use hormonal contraception and give
a negative urine Human Chorionic Gonadotropine test
prior to inclusion.
Each participant was screened for the above criteria on
the day of the trial and gave their written informed
consent before trial inclusion.
Incision lines
Before block performance, two hypothetical incisions
were drawn on each side of the participants’ hips,
corresponding to the posterior [17] and lateral [18]
approaches for THA. It should be noted that the lateral
approach for any practical conditions corresponds to the
anterolateral approach with respect to skin incision. The
lines were approximately 9–13 cm in length. This was
done by author LB, who is an orthopedic surgeon
specialized in THA surgery. The incisions were drawn
with ultraviolet (UV) paint (SkinSafe UV12 blue reflec-
tion, J & Maya, Denmark), only visible when exposed to
UV light. To ensure that only the orthopedic surgeon
knew the exact placement of the incision lines, drawing
of the incision lines took place behind a curtain and with
blindfolding of the participants.
Randomization and blinding
Participants were enrolled and allocated at random into
two groups. Group A received a LFCN-block with 8 mL
ropivacaine 0.75% on their right side and a LFCN-block
containing 16mL ropivacaine 0.75% on the left side.
Group B received 16mL ropivacaine 0.75% on the right
side and 8mL ropivacaine 0.75% on their left side.
The pharmacy of The Capital Region (Herlev, Denmark)
prepared a computer-generated simple randomization list
(1:1 ratio) of identification (ID) numbers and cognate allo-
cation group, and packed the trial medicine in accordance,
one medicine package for each ID number. The ID num-
bers were assigned consecutively. Each medicine package
included two identical ampoules containing 20mL ropiva-
caine 0.75%. Ampoules were labelled with respect to
which volume to administrate to which side. Due to the
volume difference, it was possible to visualize which side
would be given the larger dose. The anesthesiologist (JKD)
who administered the blocks could not be blinded and
was therefore not further involved in the study. The
preparation of the trial medicine was double-checked by a
person not otherwise involved in the trial. To assure
blinding of outcome assessors and participants, block
performance took place behind a curtain and participants
were blindfolded throughout the preparation and adminis-
tration of the nerve blocks.
Nerve block procedure
Intravenous access, standard monitoring and baseline
measurements were obtained before the block procedure.
For the block procedure we used a Philips Sparq ultra-
sound system with a 4–12MHz linear probe (Phillips,
Netherlands) and a Pajunk SonoPlex 22G × 80mm needle.
With the patient in a supine position and the legs
extended in neutral position, the transducer was placed
parallel to the IL. With the femoral artery and vein as
guidance the lateral part of the sartorius muscle and fascia
latae was visualized. Approximately 3 cm inferior from
this point, the branches of the lateral femoral cutaneous
nerve was visualized in the hypoechoic fat-filled subfascial
space between the sartorius muscle medially and the
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tensor fascia latae muscle laterally (Fig. 1). We used in
plane approach and the needle was inserted at a shallow
angle to reach the area of the nerve. The injection and
spread of the local analgesics were visualized sonographi-
cally. The LFCN-block was performed on the right side
first, immediately followed by the left side. Participants
were monitored for 30min after receiving the blocks.
Failed blocks were predefined as preserved sensibility one
hour after block performance when testing temperature
discrimination in the examination area, described later.
Outcomes assessment
Participants were introduced to all assessment measure-
ments and baseline values were recorded prior to block
procedure.
Assessment of outcome measures was done one-hour
post-block to ensure full onset of the block. The affected
area (blocked area) was assessed using two tests – a
temperature discrimination test and a mechanical dis-
crimination test (pinprick). Temperature discrimination
is the ability to sense coldness when applying an alcohol
soaked gauze to the skin, and pinprick is the ability to
recognize sharp sensation when stimulating with a Von
Frey filament (Somedic Senselab, size 19, pressure 137.3
g/mm2). To ensure a systematical exploration of the
blocked areas, a line denoted “A” was drawn from the
greater trochanter to the lateral epicondyle of the femur.
This line was extended cranially. A line labelled “0A”
was drawn perpendicular to line “A” at the point of the
greater trochanter. Five cm above “0A” another line, also
perpendicular to line “A”, was drawn and denoted “-1A”.
Five cm beneath “0A” another line was drawn and
denoted “1A”. Lines up until “15A” where drawn (Fig. 2).
Testing with temperature discrimination test and
pinprick along the above described lines, ensured a
standardized way of measuring the blocked area on each
leg of each participant. The blocked areas were marked
and mapped with both measurements before the incision
lines were visualized. The length and coverage of the in-
cision lines for both temperature discrimination test and
pinprick were recorded.
Furthermore, maximum pain during tonic heat stimu-
lation (THS) was assessed using the Visual Analogue
Scale (VAS) score (0–100 mm) (No pain: VAS = 0, worst
pain imaginable: VAS = 100) to mimic the postoperative
pain from incisions. This was done using a computer-
controlled thermode (Modular Sensory Analyzer Ther-
mal Stimulator, 2.5 cm2, Thermotest; Somedic A/B,
Sweden) heated to 450 C for 30 s. Two distinct measure-
ments were recorded for each incision, one for the
superior (cranial) part of the incision, and one for the in-
ferior (caudal) part of the incision (baseline values were
obtained by stimulating the skin superficial to the
greater trochanter).
The maximal voluntary isometric contraction (MVIC)
of the quadriceps muscle was measured with the partici-
pant sitting in an upright position, with their arms
across the chest and a dynamometer in fixed position
slightly above the ankle anteriorly. MVIC of the quadri-
ceps femoris muscle were calculated in kilograms of
force for each leg by the mean of three consecutive mea-
surements. We predefined a decrease in MVIC to < 80%
of baseline as clinically relevant.
Outcome measures
All outcomes compared the sides given 8 mL ropivacaine
with the sides given 16 mL ropivacaine. The primary
outcome was: Difference in the percentage coverage of
the posterior incision assessed by temperature discrimin-
ation test.
Secondary outcome measures were: Difference in
percentage coverage of posterior incision assessed by
pinprick (1 outcome); difference in the percentage cover-
age of the lateral incision assessed by both temperature dis-
crimination test and pinprick (2 outcomes); difference in
total blocked area assessed by temperature discrimination
Fig. 1 Ultrasound image of the target nerve. The image is not from an actual trial participant. SAR = sartorius muscle. LFCN = lateral femoral
cutaneous nerve. TFL = tensor facia latae muscle. * marks the anterior superior iliac spine
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test and pinprick (2 outcomes); difference in number of
patients feeling no pain (defined as VAS = 0mm) assessed
by maximum pain during THS test on the superior and
inferior part of either incision lines (4 outcomes); and the
difference in MVIC of the knee joint compared to baseline
MVIC values (1 outcome).
Statistical analysis
In a study from 2014 the mean percentage coverages
of the incision lines were reported to be between
10.1–21.3% with a standard deviation (SD) of 15.7–
24.5% [11]. We aimed to show an increase in cover-
age of the incision line from 20 to 40% by doubling
the volume of ropivacaine injected from 8mL to 16mL.
In a paired design with a type 1 error rate of 5%, a type 2
error rate of 10%, and an estimated SD of 25%, 18 partici-
pants were needed to show an increase in coverage from
20 to 40%. Taking the unknown true SD into account, we
chose to enroll 20 participants.
Data were entered into two spreadsheets by two
authors (FV and MN) and thereafter cross-checked for
typos before further analysis. Using histograms, QQ-
plots, and Shapiro-Wilk test, the outcomes regarding the
incision lines showed non-normal distribution, whereas
all other outcome measures showed normal distribution.
We used Wilcoxon-Signed rank test and Hodges-Leh-
mann estimator for non-normally distributed data and
paired t-test for normally distributed data. Chi-squared
test and Fisher’s Exact test were used as appropriate (IBM
SPSS statistics, release 24.0, IBM Corporation, Armonk,
USA). The unblinding of the treatment allocation was
done in two steps. First step unveiled the group allocation
of participants. Calculations were completed, and
conclusions drawn, before the final disclosure of the
volumes administered in each group. A p-value of < 0.05
was considered statistically significant.
Results
Fifty individuals were screened for eligibility, 30 were ex-
cluded and 20 were enrolled (Fig. 3). Eleven participants
were allocated to treatment A and nine to treatment B.
All enrolled participants received the intervention and
completed the trial. Demographics and baseline values are
shown in Table 1. We observed one failed block (2.5%).
The median coverage of the posterior incision assessed by
temperature discrimination test was 0.0% (IQR 0.0 to 0.0)
in the 8 mL group and 0.0% (IQR 0.0 to 2.5) in the
16 mL group with a difference of 0.0% (95% CI: 0 to
3.5; p = 0.345). The other outcomes regarding the
incision lines are shown in Table 2.
The blocked sensory area was significantly larger in
the 16 mL group compared with the 8 mL group when
assessed by both temperature discrimination test and
pinprick. The mean difference of the area assessed by
temperature discrimination was 146.3 cm2 (95% CI:
35.7–256.9; p = 0.012), while the mean difference of the
area assessed by pinprick was 92.2 cm2 (95% CI: 7.8–
176.6; p = 0.034) (Table 2).
We observed a decrease in MVIC to less than 80% of
baseline values in 2 of 20 legs receiving 8 mL ropivacaine
and 2 of 20 legs receiving 16mL ropivacaine (Table 2).
Fig. 2 Mapping of blocked areas. Sketch showing how to draw guiding lines for the mapping of the blocked area, 0A marks the point of the
greater trochanter. Red lines border the blocked area which was mapped using temperature discrimination test. Green lines border the blocked
area which was mapped using pinprick. The purple line corresponds to the posterior incision line. The blue line corresponds to the lateral incision
line. The drawn sketch has previously been published in “Sensory distribution of the lateral femoral cutaneous nerve block – a randomised,
blinded trial.” Nersesjan M, Acta Anaesthesiologica Scandinavica volume 62 issue 6, Copyright© 2018, The Acta Anaesthesiologica Scandinavica
Foundation. Published by John Wiley & Sons Ltd.
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None of the participants experienced bilateral decrease
in MVIC to less than 80% of baseline.
No adverse events, both related or unrelated to the trial
medication, were observed during the trial. Likewise, no
participants reported any discomfort or paresthesia after
the trial has ended.
Discussion
This trial showed that using 16mL 0.75% ropivacaine
instead of 8 mL 0.75% ropivacaine for LFCN-block did
not result in a larger coverage of the posterior or lateral
incision lines typically used for THA [19, 20]. However,
we observed a larger sensorial blocked area on the side
receiving 16 mL compared with 8 mL ropivacaine. There
was no difference in the number of participants with a
decrease of 20% or more in MVIC of the quadriceps
femoris muscle compared with baseline values.
The analgesic effect of nerve blocks after THA surgery
is well established [5], however, the role of the LFCN-
block in this setting is uncertain. As stated, an 8 mL
ropivacaine 0.75% LFCN-block may relieve movement
related pain among THA patients with moderate to se-
vere pain to a certain degree, but with a relatively high
non-responder rate [8]. We found no increase in cover-
age of the incision lines using 16 mL compared with 8
mL in this clinical model of healthy volunteers. Based on
these results, we find it unlikely that a larger volume
would lower the non-responder rate in the setting of
THA surgery using the investigated approaches. It is
theoretically possible that minimally invasive THA
procedures utilizing smaller incisions could benefit
more, but this has yet to be investigated.
Injecting a larger volume of local anesthetics into the
LFCN canal, however, did result in a larger blocked area,
which may indicate the involvement of additional nerve
branches. When dot plotting the blocked areas (Fig. 4)
we saw that the blocks affected a generally larger area
without spreading in any particular direction of the
thigh. As hypothesized by Nielsen and colleagues [10] a
larger volume injected in the LFCN-canal could spread
to the proximal branch of LFCN. Our trial, however, did
not confirm this hypothesis.
The increase in blocked area was approximately 30%
and with no association between decrease in MVIC and
a larger blocked area. The increase in area did not result
in a better coverage of any of the tested incision lines for
THA. Other types of surgery, as e.g., femoral fractures
or plastic surgery procedures on the thigh may
theoretically benefit from this larger blocked area.
This trial has the strengths of being blinded (partici-
pants, outcome assessors, and during statistical analyses)
and designed with a bilateral setup, thereby limiting bias
caused by anatomical variation between individuals.
Furthermore, this trial (with respect to the 8mL group)
has the strength of reproducing the findings of Nersesjan
and co-workers [12], which used the same methodology
regarding block procedure and outcome assessment.
There are several limitations to this trial. First, the
block technique used may not be ideal to block all
branches of the LFCN, especially branches that cross
posterior to the ASIS. A different technique (e.g. a more
proximal approach to the LFCN) may yield a better
coverage of the incision lines, or a larger area blocked.
Secondly, the incision lines drawn by the experienced
orthopedic surgeon in this trial may not resemble the
incision lines used by other surgeons. The surgeon was
instructed to draw the incision lines as he would have if
Fig. 3 Consort flowchart
Table 1 Demographics and baseline values
Variable Mean (Range)
Age, [years] 25 (19–49)
Sex, male/female 13/7
Height, [cm] 176 (164–186)
Weight, [kg] 70 (55–85)
Quadriceps femoris, MVIC, [kg] Right leg
Left leg
41
44
(26–58)
(26–63)
Heat stimulation, VAS, [mm] Right leg
Left leg
41
44
(9–96)
(11–94)
MVIC =Maximum Voluntary Isometric Contraction, VAS=Visual Analogue Score
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he were to perform THA surgery. Incision lines may vary
between surgeons due to different patient characteristics
and experience, or preferences, of the surgeon. Further-
more, they may not exactly match examples in textbooks.
Thirdly, the spread of the local anesthetic and the
occurrence of failed blocks may vary between patients
who have undergone THA surgery and healthy volunteers.
This could be due to demographical differences, e.g. Body
Mass Index, the surgical trauma, and, perhaps, the indica-
tion for THA in the first place (femoral neck fracture,
osteoarthritis, osteonecrosis, etc.). This trial had all nerve
block administered by an anesthesiologist who specializes
in peripheral nerve blocks, which could explain the low
failed block rate (2.5%).
Table 2 Outcomes
Variable Group 8 mL Group 16mL Difference and 95% CI P
Coverage of posterior incision by temperature discrimination test, % 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–3.5) 0.345
Coverage of lateral incision by temperature discrimination test, % 0.0 (0.0–19.3) 19.5 (0–45.3) 7.8 (−2.6–24.5) 0.221
Coverage of posterior incision by mechanical discrimination test, % 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.0 (0.0–0.0) 0.715
Coverage of lateral incision by mechanical discrimination test, % 0.0 (0.0–20.3) 0.0 (0.0–29.5) 3.9 (0.0–16.5) 0.110
Blocked area assessed by temperature discrimination test, cm2 418 (225.0) 564 (182.7) 146.3 (35.7–256.9) 0.012
Blocked area assessed by mechanical discrimination test, cm2 369 (211.4) 461 (156.0) 92.2 (7.8–176.6) 0.034
Post-block MVIC ≤80% of baseline, n 2 2 1.00
No pain during THS at superior portion of posterior incision, n 0 0 1.00
No pain during THS at superior portion of lateral incision, n 0 0 1.00
No pain during THS at inferior portion of posterior incision, n 0 1 1.00
No pain during THS at inferior portion of lateral incision, n 2 2 1.00
Coverage outcomes are reported as medians (IQR). Blocked areas are reported as means (SD). Maximal voluntary isometric contraction (MVIC) are reported as
number of participants. Pain during tonic heat stimulation (THS) are reported as number of participants feeling no pain
Fig. 4 Area dot-plots. Blocked areas assessed with temperature discrimination for each participant, identification number given. The green dot
marks 0A (the point of the greater trochanter). Blue lines represent the side given 8 mL. Orange lines represent the side given 16 mL
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Fourthly, the dose of ropivacaine was rather high in
the 16mL group (120 mg), especially if the LFCN-block
were to be combined with other blocks. To resemble a
clinical situation, a 16 mL diluted ropivacaine solution
(i.e. 3.75 mg/mL) could have been used.
Lastly, this trial assumed that there were no intra-indi-
vidual anatomical differences between the participants’
right and left sides. This was not further investigated
and therefore might have influenced the results.
Further research should focus on combining LFCN
with other nerve block techniques (e.g. the transmus-
cular quadratus lumborum-block [21–23], posterior
femoral cutaneous nerve block, or an iliohypogastric
block) to obtain a better coverage of the posterior
incision lines after THA, or clinical trials investigating
the analgesic effects of LFCN-block in THA patients
using the lateral approach.
Conclusions
In conclusion, a LFCN-block with 16 mL ropivacaine
0.75% did not result in a larger coverage of the pos-
terior incision used for THA compared with a LFCN-
block consisting of 8 mL ropivacaine 0.75%. It did,
however, increase the blocked area. Based on results
from this trial we cannot recommend increasing the
volume of ropivacaine used in LFCN-blocks to
achieve a larger coverage of incisions used in THA.
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